These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [FACTORS IN THE DEVELOPMENT OF EDEMA AND DIURETICS]. ASANO S Sogo Rinsho; 1963 Aug; 12():1460-6. PubMed ID: 14048238 [No Abstract] [Full Text] [Related]
4. [ALDOSTERONE AND SPIROLACTONES IN THE CLINICAL TREATMENT OF INTERNAL DISEASES (REVIEW OF THE LITERATURE AND ANALYSIS OF PERSONAL CASES)]. POLIANTSEVA LR; ERMOLENKO VM Sov Med; 1963 Dec; 27():42-51. PubMed ID: 14150357 [No Abstract] [Full Text] [Related]
6. [THE CAUSE AND TREATMENT OF CHRONIC CARDIAC INSUFFICIENCY]. SASAMOTO H; OKAZAKI K; TAKIZAWA S Chiryo; 1964; 46():210-6. PubMed ID: 14128073 [No Abstract] [Full Text] [Related]
7. [THE WATER-ELECTROLYTE STATE IN EDEMA CAUSED BY CONGESTIVE CARDIO-CIRCULATORY INSUFFICIENCY. PHYSIOPATHOGENETIC CONSIDERATIONS AND THERAPEUTIC TRENDS]. POLIMENI R; MARCHESE G Rass Clin Ter; 1964; 63():13-44. PubMed ID: 14127189 [No Abstract] [Full Text] [Related]
8. EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE. CARRUTHERS BM; LEDRAY RD; SERAGLIA M; MCINTOSH HW; WALSH GC Can Med Assoc J; 1963 Sep; 89(13):633-41. PubMed ID: 14077808 [TBL] [Abstract][Full Text] [Related]
9. [MEASUREMENT OF ALDOSTERONE SECRETION DURING THE ADMINISTRATION OF A SEMI-SYNTHETIC ADRENOSTATIC AGENT, HEPARINOID RO I-8307]. VEYRAT R; MANNING EL; FABRE J; MULLER AF Rev Fr Etud Clin Biol; 1963; 8():667-73. PubMed ID: 14082398 [No Abstract] [Full Text] [Related]
10. Aldosterone metabolism in cardiac failure. Hickie JB; Lazarus L Australas Ann Med; 1966 Nov; 15(4):289-300. PubMed ID: 5972581 [No Abstract] [Full Text] [Related]
11. [Apparently irreducible cardiac edema. Remarkable effect of a spirolactone]. VIALA JJ; FATH A Lyon Med; 1961 May; 93():1217-20. PubMed ID: 13781098 [No Abstract] [Full Text] [Related]
12. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE]. HIERHOLZER K Dtsch Med Wochenschr; 1964 Jun; 89():1124-7. PubMed ID: 14152369 [No Abstract] [Full Text] [Related]
13. [Physiopathological bases of diuresis]. VEYRAT R Helv Med Acta; 1962 Oct; 29():311-43. PubMed ID: 13996992 [No Abstract] [Full Text] [Related]
14. [Diuretic and saluretic action of an aldosterone antagonist (spirolactone, SC-9420) associated with an iso-indoline derivative (Hygroton) in refractory cardiac edema]. STRATA A; PREIS H Boll Soc Ital Cardiol; 1962; 7():106-14. PubMed ID: 13917659 [No Abstract] [Full Text] [Related]
15. INTRACTABLE HEART FAILURE--MANAGEMENT WITH 5 TO 7 DAYS OF FASTING. A PRELIMINARY TRIAL. MERRILL AJ Am Heart J; 1964 Apr; 67():433-6. PubMed ID: 14138806 [No Abstract] [Full Text] [Related]
16. [Clinical use of concurrent antagonists of aldosterone in patients with cardiac insufficiency]. Smolenskiĭ VS; Gel'fond MB; Khodzhamirov VS; Samosiuk IM Kardiologiia; 1969 Jun; 9(6):13-9. PubMed ID: 5806633 [No Abstract] [Full Text] [Related]
17. [Aldostegone-antagonistic steroids as diuretics. Spironolactone in the treatment of hepatic and cardiac edemas]. LEPPLA W; TIEFENSEE H Dtsch Med Wochenschr; 1961 Dec; 86():2395-402. PubMed ID: 14464199 [No Abstract] [Full Text] [Related]
18. The effect of digitalis and a mercurial diuretic on the electrolyte balance in patients with congestive heart failure. CHAPMAN DW; SHAFFER CF Am Pract Dig Treat; 1950 Nov; 1(11):1172-6. PubMed ID: 14771430 [No Abstract] [Full Text] [Related]
19. [EFFECT OF AN ALDOSTERONE ANTAGONIST IN THERAPY RESISTANT EDEMAS]. BARTOS V; KVASNICKA J; GROH J; ERBEN J Z Gesamte Inn Med; 1964 Jul; 19():588-91. PubMed ID: 14232020 [No Abstract] [Full Text] [Related]